Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Workplace program aims to bust age stereotypes

NCT ID NCT07484165

Knowledge-focused Sponsor: University of Salamanca Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 12-session psychoeducational program designed to reduce negative attitudes toward older workers and improve well-being at work. Researchers will recruit 90 employed adults who frequently work with colleagues of different generations. Half will take the program, and half will receive a single educational session. The goal is to see if the program can reduce ageism and boost job satisfaction, social support, and psychological flexibility.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Psychoeducational programme
What this could lead to
If successful, this could provide a practical, evidence-based program to reduce age-related stereotypes and improve job satisfaction and well-being in diverse workplaces.
What could go wrong
This is a small, early-stage trial (90 participants) testing a behavioral intervention, so results may not apply broadly. The program requires regular attendance, and benefits may not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Currently employed with at least five years of tenure in the organization or the relevant sector. At this stage of their career, attitudes toward colleagues from different generations are considered more likely to be deeply ingrained, making this profile particularly suitable for the intervention. * Performing tasks that involve frequent collaboration with colleagues from different generations. * Ability and willingness to attend the program sessions regularly. Exclusion Criteria: Workers who meet any of the following conditions will be excluded from the study: * Significant reading or linguistic comprehension difficulties that prevent them from participating adequately in psychoeducational sessions or completing assessment instruments. * Serious and destabilised medical or psychological disorders that may interfere with the normal development of the programme (e.g., severe untreated depressive episodes, limiting neurological disorders). * Failure to meet the inclusion criteria, specifically not having been with the company for at least five years or not participating in intergenerational teams. * Refusal to sign the informed consent form or lack of availability to attend programme sessions regularly.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGEISM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Ageism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGEISM Job satisfaction Workers

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.